spacer
home > ebr > winter 2018 > gut feeling
PUBLICATIONS
European Biopharmaceutical Review

Gut Feeling

Vaccination is one of the most efficient and cost-effective medical interventions that exist. Being healthy is the most important thing in life, and preventing illness is something to strive for. Diarrhoeal diseases, respiratory infections, malaria, HIV/AIDS and tuberculosis are infectious diseases that globally harvest the most casualties, with the deaths of over 1 million children under the age of five caused by diarrhoea-contracted diseases alone every year.

Vaccination has made an enormous contribution to global health. Immunisation saves 2-3 million deaths every year from diphtheria, tetanus, pertussis and measles. However, an additional 1.5 million deaths could be avoided if global vaccination coverage improves. Despite these successes, approximately 7 million children still die each year, and about a half of these mortalities are caused by infections, which could be prevented by vaccination.

Several aspects of health economics should be considered for vaccines. The benefits of vaccination extend beyond prevention of specific diseases in individuals, enabling a rich, multifaceted harvest for societies and nations. It also makes good economic sense and meets the need to care for the weakest members of society. Reducing global child mortality rates by facilitating universal access to safe vaccines of proven efficacy is a moral obligation for the international community as a human right exists for every individual to have the opportunity to live a fuller, healthier life.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Björn Sjöstrand is the founder and Chief Executive Officer at Scandinavian Biopharma. He has extensive experience in the vaccine industry and has held many executive positions in Swedish and international companies. Björn has held positions including Chief Executive Officer of SBL Vaccines, Chief Executive Officer at Berna Biotech AG, Chief Business Officer at Crucell NV, Non-Executive Director at European Vaccine Manufacturers and a member of the Global Alliance for Vaccination and Immunisation. He also holds several board positions in both private and public companies and has been an advisor to the Bill and Melinda Gates Foundation.
spacer
Björn Sjöstrand
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

York Health Economics Consortium offers an updated training event

Health economics evidence is a key element in much health services research and particularly in health technology assessments, including submissions for NICE single technology appraisals. Identifying economic evidence to inform submissions involves searches in a range of databases and uses a variety of strategies.
More info >>

White Papers

The Promise and Challenge of Adaptive Design in Oncology Trials

Medpace

Clinical oncology trials are more complex and time consuming than those in any other therapeutic area and failure rates are frustratingly high. Given the urgent need for new oncologic therapies, sponsors are eager to find more effective ways to conduct clinical research. Incorporating adaptive design methodologies into clinical trials can reduce costs and enhance efficiency while maintaining trial integrity. They can also reduce the number of patients on placebo and sub-therapeutic doses. In light of this promise, regulatory bodies have created guidelines supportive of adaptive design.
More info >>

 
Industry Events

T3: Trials, Tech and Transformation

30-31 May 2018, Raleigh Convention Center, Raleigh, NC

T3 is back for 2018 to provide you with the latest updates and top tips from across the clinical trials landscape. Connecting leading experts, influencers and innovators from pharma, biotech, CROs, patient advocacy groups, academia and beyond, T3 is themeeting place for all stakeholders to voice their questions, connect with peers, and get direct feedback from an expert speaker line-up.And this year, we're in Raleigh.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement